Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-05

Clinical Trial Update: Oothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an 8% arginine toothpaste to Colgate Cavity Protection toothpaste for reducing dentinal hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 8% Arginine Toothpaste (experimental) (arginine-containing toothpaste)
  • Colgate Cavity Protection toothpaste (toothpaste)

Snippet

Sponsor: Colgate Palmolive | Conditions: Hypersensitivity | Phase 3 | Status: COMPLETED